Vesselin Dimov to Humans
This is a "connection" page, showing publications Vesselin Dimov has written about Humans.
Connection Strength
0.097
-
Social Media and Allergy. Curr Allergy Asthma Rep. 2018 11 14; 18(12):76.
Score: 0.019
-
Pharmacokinetic drug evaluation of mepolizumab for the treatment of severe asthma associated with persistent eosinophilic inflammation in adults. Expert Opin Drug Metab Toxicol. 2017 Dec; 13(12):1275-1280.
Score: 0.018
-
Investigational drugs for the treatment of allergic rhinitis. Expert Opin Investig Drugs. 2014 Jun; 23(6):823-36.
Score: 0.014
-
Pharmacokinetic evaluation of topical calcineurin inhibitors for treatment of allergic conjunctivitis. Expert Opin Drug Metab Toxicol. 2014 Apr; 10(4):543-9.
Score: 0.014
-
Innovations in technology: social media and mobile technology in the care of adolescents with asthma. Curr Allergy Asthma Rep. 2012 Dec; 12(6):607-12.
Score: 0.013
-
Immunomodulators in asthma therapy. Curr Allergy Asthma Rep. 2009 Nov; 9(6):475-83.
Score: 0.010
-
Olopatadine hydrochloride ophthalmic solution for the treatment of allergic conjunctivitis. Expert Opin Pharmacother. 2017 Aug; 18(11):1137-1143.
Score: 0.004
-
World Allergy Organization Anaphylaxis Guidelines: 2013 update of the evidence base. Int Arch Allergy Immunol. 2013; 162(3):193-204.
Score: 0.003
-
Pharmacokinetic evaluation of olopatadine for the treatment of allergic rhinitis and conjunctivitis. Expert Opin Drug Metab Toxicol. 2011 Dec; 7(12):1593-9.
Score: 0.003